...
首页> 外文期刊>Perfusion >Serum level of sCD163, a soluble receptor for hemoglobin, is influenced by cardiac surgery.
【24h】

Serum level of sCD163, a soluble receptor for hemoglobin, is influenced by cardiac surgery.

机译:sCD163(血红蛋白的可溶性受体)的血清水平受心脏手术的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The scavenger receptor for complexes hemoglobin-haptoglobin (CD163), which is expressed on monocytes/ macrophages, is shed to the body fluids in a soluble form (sCD163). OBJECTIVES: To evaluate the dynamics of sCD163 in the blood of patients undergoing cardiac surgery. PATIENTS AND METHODS: Sixty-one adult patients who underwent coronary artery bypass grafting (CABG) were enrolled in the study. They were assigned to undergo CABG using either cardiopulmonary bypass (CPB), "on-pump", (22 patients), modified CPB, mini "on-pump", (17 patients) or without CPB, "off-pump", (22 patients) surgery. Serum levels of sCD163 in venous blood samples taken before and after surgery, and during an early postoperative period, were evaluated by Macro 163(TM) diagnostic kit (IQ Products, Groningen, NL). RESULTS: Compared to the preoperative levels ("on-pump"; 344 ng/mL, "off-pump"; 314.5 ng/mL, mini-invasive "on-pump"; 336.5 ng/mL) serum levels were elevated at the finish of surgery, reaching maximum at the 1(st) postoperative day ("onpump"; 658 ng/mL; p<0.05, "off-pump"; 810.5 ng/mL; p<0.01; mini-invasive "on-pump"; 663 ng/mL; non-significant).No significant differences regarding the serum levels of sCD163 between different surgical approaches were found. CONCLUSION: Serum level of sCD163 scavenger molecule for hemoglobin is elevated at the end of surgery and at the 1(st) postoperative day, being little influenced by cardiopulmonary bypass.
机译:背景:在单核细胞/巨噬细胞上表达的复合物血红蛋白-触珠蛋白(CD163)的清除剂受体以可溶性形式(sCD163)释放到体液中。目的:评估心脏手术患者血液中sCD163的动态。患者与方法:纳入了61例行冠状动脉搭桥术(CABG)的成年患者。他们被指定接受CABG手术,包括体外循环(CPB),“泵上”,(22例),改良型CPB,小型“泵上”,(17例)或不使用CPB,“泵外”,( 22例)手术。通过Macro 163 TM诊断试剂盒(IQ Products,Groningen,NL)评估手术前后和术后早期静脉血样品中sCD163的血清水平。结果:与术前水平(“泵上”; 344 ng / mL,“泵外”; 314.5 ng / mL,微创“泵上”; 336.5 ng / mL)相比,术前血清水平升高手术结束,在术后第一天达到最大值(“泵上”; 658 ng / mL; p <0.05,“泵外”; 810.5 ng / mL; p <0.01;微创“泵上” ”; 663 ng / mL;无显着性。未发现不同手术方法之间关于sCD163血清水平的显着差异。结论:在手术结束时和术后第一天,sCD163清除剂分子的血红蛋白水平升高,几乎不受体外循环的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号